to continue leading independent lives for longer. 60. he chuckles. i ve forgotten already now. i ve lost the plot, sorry. that s ok. in alzheimer s, a rogue protein called amyloid builds up around neurons, destroying connections. donanemab is an antibody which binds to amyloid. this prompts immune cells to attack and clear amyloid from the brain. so, lots of toxic amyloid protein. you can see it clearly in these scans. this patient starts with a lot of amyloid shown in green, yellow and red but after six months on donanemab, most of the amyloid has been removed. this is really significant. i mean, this is one of the biggest breakthroughs, insomuch as this disease is a pandemic. it s getting more and more common. and being able to both remove the amyloid protein and demonstrate that that
in alzheimer s, a rogue protein called amyloid builds up around neurons, destroying connections. donanemab is an antibody which binds to amyloid. this prompts immune cells to attack and clear amyloid from the brain. so, lots of toxic amyloid protein. you can see it clearly in these scans. this patient starts with a lot of amyloid shown in green, yellow and red but after six months on donanemab, most of the amyloid has been removed. this is really significant. i mean, this is one of the biggest breakthroughs, insomuch as this disease is a pandemic. it s getting more and more common. and being able to both remove the amyloid protein and demonstrate that that correlates with the slowing, or hopefully steadying of symptoms, is life changing. so a moment of hope? a moment of enormous hope. this is fantastic. hello. are you ready to come through? yes. all right. donanemab could be licensed here within a year, butjanet north is hoping to get it sooner,
donanemab is an antibody which binds to amyloid. this prompts immune cells to attack and clear amyloid from the brain. so, lots of toxic amyloid protein. you can see it clearly in these scans. this patient starts with a lot of amyloid shown in green, yellow and red but after six months on donanemab, most of the amyloid has been removed. this is really significant. i mean, this is one of the biggest breakthroughs, insomuch as this disease is a pandemic. it s getting more and more common. and being able to both remove the amyloid protein and demonstrate that that correlates with the slowing, or hopefully steadying of symptoms, is life changing. so a moment of hope? a moment of enormous hope. this is fantastic. hello. are you ready to come through? yes. all right. donanemab could be licensed here within a year, butjanet north is hoping to get it sooner,
neurons, destroying connections. donanemab is an antibody which binds to amyloid. this prompts immune cells to attack and clear amyloid from the brain. so, lots of toxic amyloid protein. you can see it clearly in these scans. this patient starts with a lot of amyloid shown in green, yellow and red but after six months on donanemab, most of the amyloid has been removed. this is really significant. i mean, this is one of the biggest breakthroughs, in so much as this disease is a pandemic. it s getting more and more common. and being able to both remove the amyloid protein and demonstrate that that correlates with the slowing, or hopefully steadying of symptoms, is life changing. so a moment of hope? a moment of enormous hope. this is fantastic. hello. are you ready to come through? yes. all right.